Сolorectal cancer screening: how the problem is solved in Russia and the world
https://doi.org/10.31146/1682-8658-ecg-205-9-183-189
Abstract
Colorectal cancer is an urgent health problem in Russia and other countries. The aim is to present up-to-date data on CRC screening programs. A review of current recommendations has shown the effectiveness of screening programs using occult blood tests and fibrocolonoscopy in reducing morbidity and mortality from colorectal cancer. The implementation of screening programs in Russia is presented as part of the development of preventive medicine in general.
About the Authors
E. A. Lyalyukova
Omsk State Medical University
Russian Federation
Russian Federation
L. A. Amanatidis
Maykop State Technological University
Russian Federation
Russian Federation
G. M. Konovalova
Maykop State Technological University
Russian Federation
Russian Federation
S. Yu. Ovsyannikova
Maykop State Technological University
Russian Federation
Russian Federation
References
1. Ansa B.E., Coughlin S. S., Alema-Mensah E., et al. Evaluation of Colorectal Cancer Incidence Trends in the United States (2000-2014). J Clin Med.2018;7(22):310-321. doi:10.3390/jcm7020022
2. Sung H., Ferlay J., Siegel R. L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A CANCER Journal for Clinicians. 2021;71(3):209-249. doi: 10.3322/caac.21660
3. Oskombaev M. Sh., Dzhekshenov M. D., Satybaldiev O. A., et al. Epidemiology of colorectal cancer. Scientific review. Medical sciences.2021;1(7):37-42. (In Russ.) doi:10.17513/srms.1169 @@Осомбаев М. Ш., Джекшенов М. Д., Сатыбалдиев О. А. и соавт. Эпидемиология колоректального рака. Научное обозрение. Медицинские науки. 2021;1(7):37-42. doi:10.17513/srms.1169
4. Kaprin A.D., Starinsky V. V., Shakhzadova A. O., et al. Malignant neoplasms in Russia in 2019 (morbidity and mortality). Moscow. P. A. Herzen Moscow State Medical Research Institute - Branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia. 2020;(1):72-79. (In Russ.) @@Каприн А. Д., Старинский В. В., Шахзадова А. О. и соавт. Злокачественные новообразования в России в 2019 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2020;1:72-79.
5. Smith R.A., Andrews K. S., Brooks D., et al. Cancer Screening in the United States, 2019: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. CA: A CANCER Journal for Clinicians. 2019;69(3):184-210. doi:10.3322/caac.21557
6. Cancer Screening in the European Union (2017) Report on the implementation of the Council Recommendation on cancer screening. 2017, International Agency for Research on Cancer. Available at: https://ec.europa.eu/health/sites/health/files/major_chronic_diseases/docs/2017_cancerscreening_2ndreportimplementation_en.pdf (accessed: 05.05.2021.)
7. Siegel R. L., Fedewa S. A., Anderson W. F., et al. Colorectal cancer incidence patterns in the United States. 1974-2013. J Natl Cancer Inst. 2017;109(8):1-6. doi:10.1093/jnci/djw322
8. Chen F. W., Sundaram V, Chew T. A., et al. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol.2017;15:728-737, e723. doi:10.1016/j.cgh.2016.10.038
9. Scott R. B., Rangel L. E., Osler T. M., et al. Rectal cancer in patients under the age of 50 years: the delayed diagnosis. Am J Surg. 2016;211(6):1014-1018. doi:10.1016/j.amjsurg.2015.08.031
10. Siegel R.L., Miller K. D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7-30. doi: 10.3322/caac.21387
11. Giardiello F.M., Allen J. I., Axilbund J. E., et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2014;147(2):502-526. doi:10.1053/j.gastro.2014.04.001
12. Wood M.E., Kadlubek P., Pham T. H., et al. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol. 2014;32(8):824-829. doi: 10.1200/JCO.2013.51.4661
13. Lowery J.T., Ahnen D. J., Schroy P. C. 3rd, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the science review. Cancer. 2016;122(17):2633-2645. doi: 10.1002/cncr.30080
14. Chissov V.I., Sergeyeva N. S., Zenkina Ye.V., et al. Evolution of copro-tests in active detection of colorectal cancer. Coloproctology News. 2012;6 (In Russ.) @@Чиссов В. И., Сергеева Н. С., Зенкина Е. В., и соавт. Эволюция копро-тестов в активном выявлении колоректального рака. Новости колопроктологии. 2012;6.
15. Order of the Ministry of Health of the Russian Federation No. 404n dated April 27, 2021 “On approval of the procedure for preventive medical examination and medical examination of certain groups of the adult population”. (In Russ.) @@Приказ Министерства здравоохранения РФ № 404н от 27 апреля 2021 г «Об утверждении порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения»
16. Lee Y.C., Li-Sheng Chen S., Ming-Fang Yen A., et al. Association between colorectal cancer mortality and gradient fecal hemoglobin concentration in colonoscopy noncompliers [serial online]. J Natl Cancer Inst. 2017;109(5). pii: 2740720. doi:10.1093/jnci/djw269
17. Corley D.A., Jensen C. D., Quinn V. P., et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA. 2017;317(16):1631-1641. doi: 10.1001/jama.2017.3634
18. Selby K., Baumgartner C., Levin T. R., et al.Interventions to improve follow-up of positive results on fecal blood tests: a systematic review. Ann Intern Med. 2017;167(8): 565-575. doi: 10.7326/M17-1361
19. Passport of the national project “Healthcare”. approved by the Presidium of the Council under the President of the Russian Federation for Strategic Development and National Projects, Protocol No. 16 of December 24, 2018. (In Russ.) @@Паспорт национального проекта «Здравоохранение» (утв. Президиумом Совета при Президенте Российской Федерации по стратегическому развитию и национальным проектам, протокол от 24 декабря 2018 г. n 16)
20. FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer. Medical device aids clinicians in detecting potential irregularities during colon cancer screening and surveillance. Available at: URL: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-device-uses-artificial-intelligence-help-detect-potential-signs-colon. Accessed: 05.05.2021.
21. Yuichi Mori, Shin-ei Kudo, Masashi Misawa, et al. Artificial intelligence-assisted colonic endocytoscopy for cancer recognition: a multicenter study. Endoscopy International Open.202; 9(7): E1004-E1011. doi:10.1055/a-1475-3624
Review
For citations:
Lyalyukova E.A., Amanatidis L.A., Konovalova G.M., Ovsyannikova S.Yu. Сolorectal cancer screening: how the problem is solved in Russia and the world. Experimental and Clinical Gastroenterology. 2022;(9):183-189. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-205-9-183-189
Views:
464
Email this article 